ASX:BGT

BIO-GENE TECHNOLOGY LTD

4W AVG VOLUME

-

Data provided by Weblink | as of last close

4W AVG TURNOVER

-

BIO-GENE TECHNOLOGY LTD has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise

< $50k

Investors Interested in Next Raise

< 10

How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

2. View Terms

View the full term sheet for the capital raise.

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Company Overview

Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these ?-triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide� is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE� is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.

Type

Listed Company

GICS Sub-industry

Fertilizers & Agricultural Chemicals

Head Office

Level 12/575 Bourke St, Melbourne VIC 3000, Australia

Website

www.Bio-gene.com.au

Fertilizers & Agricultural Chemicals

Materials

Chemicals & Materials

Price Chart

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.